Immuneering CorporationIMRXNASDAQ
Loading
EPS Growth Recovery in ProgressRecovering
Percentile Rank96
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

Latest
52.63%
↓ 85% vs avg
Percentile
P96
Near historical high
Streak
2 qtr
Consecutive growthRecovering
Average
354.63%
Historical baseline
PeriodValue
Q4 202552.63%
Q3 20255.00%
Q2 20254.76%
Q1 202527.59%
Q4 2024-18.37%
Q3 2024-4.26%
Q2 20244.08%
Q1 20245.77%
Q4 2023-20.93%
Q3 20230.00%
Q2 2023-101.07%
Q1 20238644.68%
Q4 20220.00%
Q3 2022-6.82%
Q2 202210.20%
Q1 2022-16.67%
Q4 202110.64%
Q3 2021-42.42%
Q2 202128.26%
Q1 2021-6.98%
Q4 2020-30.30%
Q3 2020-22.22%
Q2 2020-12.50%
Q1 20200.00%